Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 6, 2006, Pages 1139-1144

  Gaind, R ^a   Paglietti, B ^b   Murgia, M ^b   Dawar, R ^a   Uzzau, S ^b   Cappuccinelli, P ^b   Deb, M ^a   Aggarwal, P ^a   Rubino, S ^b  

^a SAFDARJUNG HOSPITAL   (India)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

DNA gyrase; High level fluoroquinolone resistance; Integrons; Salmonella enterica serovar Paratyphi A; Topoisomerase IV

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE; DNA TOPOISOMERASE IV; NALIDIXIC ACID; PROTEIN PARC; QUINOLONE DERIVATIVE; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; TRIMETHOPRIM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG SENSITIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEQUENCE ANALYSIS; TYPHOID FEVER;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA GYRASE; DNA TOPOISOMERASE IV; DNA TOPOISOMERASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INDIA; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; PARATYPHOID FEVER; PLASMIDS; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; SEQUENCE ANALYSIS, DNA; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TYPHOID FEVER;

EID: 33845367997     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl391     Document Type: Article

References (30)

1. Crump JA, Lubsy SP, Mintz ED. The global burden of enteric fever. Bull World Health Organ 2004; 82: 346-53.
2. Bhan MK, Bhal R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005; 366: 749-62.
3. Murdoch DA, Banatvaia NA, Bone A et al. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998; 351: 339.
4. Wain J, Hoa NT, Chinh NT et al. Quinolone-resistant Salmonella typhi in Vietnam: Molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997; 25: 1404-10.
5. Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg Infect Dis 2001; 7: 448-50.
6. Ackers; ML, Puhr ND, Tauxe RV et al. Laboratory based surveillance of Salmonella serotype Typhi infections in United States - antimicrobial resistance on the rise. JAMA 2000; 283: 2668-73.
7. Walia M, Gaind R, Mehta R et al. Current perspectives of enteric fever in India - a hospital based study. Ann Trop Paediatr 2005; 25: 161-74.
8. Nair S, Unnikrishan M, Tumer K et al. Molecular analysis of fluoroquinolone-resistant Salmonella Paratyphi A isolate, India. Emerg Infect Dis 2006; 12: 489-91.
9. Adachi T, Sagara H, Hirose K et al. Fluoroquinolone-resistant Salmonella Paratyphi A. Emerg Infect Dis 2005; 11: 172-4.
10. Hirose K, Hashimoto A, Tamura K et al. DNA sequence analysis of DNA gyrase and DNA topisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother 2002; 46: 3249-52.
11. Piddock LJ, Ricci V, McLaren I et al. Role of mutation in gyrA and parC genes in nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother 1998; 41: 635-41.
12. Brown JC, Shanahan PMA, Jesudason MV et al. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multiresistant Salmonella Typhi in India. J Antimicrob Chemother 1996; 37: 891-900.
13. Cloeckaert A, Chaslus-Dancla E. Mechanism of quinolone resistance in Salmonella. Vet Res 2001; 32: 291-300.
14. Hooper DC. Mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7: 337-41.
15. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disc Susceptibility Tests - Seventh Edition: Approved Standard M2-A7 NCCLS, Wayne, PA, USA, 2002.
16. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145: 1365-73.
17. Kariuki S, Gilks C, Revathi G et al. Genotypic analysis of multidrug-resistant Salmonella enterica serovar Typhi, Kenya. Emerg Infect Dis 2000; 6: 649-51.
18. Ploy MC, Denis F, Courvalin P et al. Molecular characterisation of integrons; in Acinetobacter baumannii: Description of a hybrid class 2 integron. Antimicrob Agents Chemother 2000; 44: 2684-8.
19. Ploy MC, Chainier D, Tran Thi NH et al. Integron-associated antibiotic resistance in Salmonella enterica serovar Typhi from Asia. Antimicrob Agents Chemother 2003; 47: 1427-9.
20. Ausubel FM, Brent R, Kingston RE (eds). Current Protocols in Molecular Biology. New York: John Wiley & Sons, 1996.
21. Kariuki S, Revathi G, Muyodi J et al. Characterisation of multiresistant typhoid outbreaks in Kenya. J Clin Microbiol 2004; 42: 1477-82.
22. Peters TM, Maguire C, Threlfall EJ et al. The Salm-gene project - a European collaboration for DNA fingerprinting for food-related salmonellosis. Euro Surveill 2003; 8: 46-50.
23. Chandel DS, Chaudhry R, Dhawan B et al. Drug-resistant Salmonella entenica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6: 448-50.
24. Cebrian L, Sirvent E, Rodriguez Diaz JC. Characterization of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int J Antimicrob Agents 2003; 22: 134-9.
25. Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int J Antimicrob Agents 2005; 25: 358-73.
26. Ling JM, Chan EW, Lam AW et al. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother 2003; 47: 3567-73.
27. Renuka K, Seema S, Das B et al. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. Letter. J Med Microbiol 2005; 54: 999-1000.
28. Pai H, Byeon JH, Yu S, Lee BK et al. Salmonella enterica serovar Typhi strains isolated in Korea containing a multidrug resistance class 1 intergron. Antimicrob Agents Chemother 2003; 47: 2006-8.
29. Fluit AC. Towards more virulent and antibiotic-resistant Salmonella. FEMS Imm Mad Microbiol 2005; 43: 1-11.
30. Carattoli A, Villa L, Pezzella C et al. Expanding drug resistance through integron acquisition by IncFI plasmids of Salmonella enterica Typhiumurium. Emerg Infect Dis 2001; 7: 444-7.